Arete Therapeutics
Latest round
- Series A
Last raised
- Nov 2008
Total raised
- $68M
Investors
- 5
About Arete Therapeutics
Arete Therapeutics Inc. is a US-based company that operates as a developer of drugs to treat diabetes, and inflammatory and cardiovascular diseases.
Who invested in Arete Therapeutics
5 investors across 3 rounds
See all investors in Arete Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arete Therapeutics
Who invested in Arete Therapeutics?
Arete Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arete Therapeutics raised?
Arete Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arete Therapeutics last raise money?
Arete Therapeutics's most recent round on record is a Series A, in Nov 2008.
What does Arete Therapeutics do?
Arete Therapeutics is a pharmaceuticals company.
Where is Arete Therapeutics headquartered?
Arete Therapeutics is headquartered in Hayward, US.
Which VCs invest in companies like Arete Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arete Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Arete Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.